Methicillin-resistant Staphylococcus aureus: novel treatment approach breakthroughs
Tóm tắt
Methicillin-resistant Staphylococcus aureus (MRSA) is a common bacterial infection that is a significant source of illness and mortality globally. The advancements in antibiotic therapies continue to be the critical aspects of treating bacterial infections, and their usage has lowered patient mortality and raised life expectancy.
The ideal treatments for MRSA remain challenging, and the quest for new antibiotic targets and advanced drug delivery systems with safety profiles is necessary to ensure treating MRSA infections adequately in the future.
This article primarily focuses on different therapeutic medications and their modes of action for general microbial infections and goes through the latest developments in novel drug delivery technologies, such as hydrogels, lipid particles, nanocarriers, and polymers for MRSA treatment.
Tài liệu tham khảo
Ahmed MM (2022) MRSA infections: priorities and future approaches for research. Gastroenterol Hepatol Open Access. https://doi.org/10.15406/ghoa.2022.13.00523
Ahmad-Mansour N, Loubet P, Pouget C, Dunyach-Remy C, Sotto A, Lavigne J-P, Molle V (2021) Staphylococcus aureus toxins: an update on their pathogenic properties and potential treatments. Toxins. https://doi.org/10.3390/toxins13100677
Blaskovich MAT, Hansford KA, Butler MS, Jia Z, Mark AE, Cooper MA (2018) Developments in glycopeptide antibiotics. ACS Infect Dis 4:715–735
Bush NG, Diez-Santos I, Abbott LR, Maxwell A (2020) Quinolones: mechanism, lethality and their contributions to antibiotic resistance. Molecules. https://doi.org/10.3390/molecules25235662
Chang S, Sievert DM, Hageman JC et al (2003) Infection with vancomycin-resistant Staphylococcus aureus containing the vanA resistance gene. N Engl J Med. https://doi.org/10.1056/nejmoa025025
Chen M, Qiu B, Zhang Z, Xie S, Liu Y, Xia T, Li X (2021) Light-triggerable and pH/lipase-responsive release of antibiotics and β-lactamase inhibitors from host-guest self-assembled micelles to combat biofilms and resistant bacteria. Chem Eng J. https://doi.org/10.1016/j.cej.2021.130330
Choi M, Hasan N, Cao J, Lee J, Hlaing SP, Yoo JW (2020) Chitosan-based nitric oxide-releasing dressing for anti-biofilm and in vivo healing activities in MRSA biofilm-infected wounds. Int J Biol Macromol. https://doi.org/10.1016/j.ijbiomac.2019.10.009
Choo EJ, Chambers HF (2016) Treatment of methicillin-resistant Staphylococcus aureus bacteremia. Infect Chemother 48:267–273
Cong Y, Yang S, Rao X (2020) Vancomycin resistant Staphylococcus aureus infections: a review of case updating and clinical features. J Adv Res 21:169–176
Corey GR, Wilcox M, Talbot GH, Friedland HD, Baculik T, Witherell GW, Critchley I, Das AF, Thye D (2010) Integrated analysis of CANVAS 1 and 2: Phase 3, multicenter, randomized, double-blind studies to evaluate the safety and efficacy of ceftaroline versus vancomycin plus aztreonam in complicated skin and skin-structure infection. Clin Infect Dis. https://doi.org/10.1086/655827
Cowan ST, Shaw C, Williams RE (1954) Type strain for Staphylococcus aureus rosenbach. J Gen Microbiol. https://doi.org/10.1099/00221287-10-1-174
Crespo-Piazuelo D, Lawlor PG (2021) Livestock-associated methicillin-resistant Staphylococcus aureus (LA-MRSA) prevalence in humans in close contact with animals and measures to reduce on-farm colonisation. Ir Vet J 74:21
Durán N, Alvarenga MA, Da Silva EC, Melo PS, Marcato PD (2008) Microencapsulation of antibiotic rifampicin in poly(3-hydroxybutyrate-co-3-hydroxyvalerate). Arch Pharm Res. https://doi.org/10.1007/s12272-001-2137-7
El-Gendy AO, Samir A, Ahmed E, Enwemeka CS, Mohamed T (2021) The antimicrobial effect of 400 nm femtosecond laser and silver nanoparticles on gram-positive and gram-negative bacteria. J Photochem Photobiol B Biol. https://doi.org/10.1016/j.jphotobiol.2021.112300
Esmaeili F, Atyabi F, Dinarvand R (2007) Preparation of PLGA nanoparticles using TPGS in the spontaneous emulsification solvent diffusion method. J Exp Nanosci. https://doi.org/10.1080/17458080701393137
Espinasse A, Goswami M, Yang J, Vorasin O, Ji Y, Carlson EE (2023) Targeting multidrug resistant Staphylococcus infections with bacterial histidine kinase inhibitors. Chem Sci. https://doi.org/10.1039/D2SC05369A
Fahimirad S, Abtahi H, Satei P, Ghaznavi-Rad E, Moslehi M, Ganji A (2021) Wound healing performance of PCL/chitosan based electrospun nanofiber electrosprayed with curcumin loaded chitosan nanoparticles. Carbohydr Polym. https://doi.org/10.1016/j.carbpol.2021.117640
Fan L, Pan Z, Liao X, Zhong Y, Guo J, Pang R, Chen X, Ye G, Su Y (2023) Uracil restores susceptibility of methicillin-resistant Staphylococcus aureus to aminoglycosides through metabolic reprogramming. Front Pharmacol. https://doi.org/10.3389/fphar.2023.1133685
Feizi S, Cooksley CM, Bouras GS, Prestidge CA, Coenye T, Psaltis AJ, Wormald PJ, Vreugde S (2021) Colloidal silver combating pathogenic Pseudomonas aeruginosa and MRSA in chronic rhinosinusitis. Colloids Surfaces B Biointerfaces. https://doi.org/10.1016/j.colsurfb.2021.111675
Fergestad ME, Stamsås GA, Morales Angeles D, Salehian Z, Wasteson Y, Kjos M (2020) Penicillin-binding protein PBP2a provides variable levels of protection toward different β-lactams in Staphylococcus aureus RN4220. Microbiologyopen 9:e1057
File TM, Low DE, Eckburg PB, Talbot GH, Friedland HD, Lee J, Llorens L, Critchley I, Thye D (2010) Integrated analysis of FOCUS 1 and FOCUS 2: Randomized, doubled-blinded, multicenter phase 3 trials of the efficacy and safety of ceftaroline fosamil versus ceftriaxone in patients with community-acquired pneumonia. Clin Infect Dis. https://doi.org/10.1086/657313
Fuda CCS, Fisher JF, Mobashery S (2005) β-Lactam resistance in Staphylococcus aureus: the adaptive resistance of a plastic genome. Cell Mol Life Sci. https://doi.org/10.1007/s00018-005-5148-6
Gadade DD, Pekamwar SS (2020) Cyclodextrin based nanoparticles for drug delivery and theranostics. Adv Pharm Bull. https://doi.org/10.34172/apb.2020.022
Garoy EY, Gebreab YB, Achila OO, Tekeste DG, Kesete R, Ghirmay R, Kiflay R, Tesfu T (2019) Methicillin-resistant Staphylococcus aureus (MRSA): prevalence and antimicrobial sensitivity pattern among patients-a multicenter study in Asmara, Eritrea. Can J Infect Dis Med Microbiol 2019:8321834
Ghafoori SM, Robles AM, Arada AM et al (2021) Structural characterization of a Type B chloramphenicol acetyltransferase from the emerging pathogen Elizabethkingia anophelis NUHP1. Sci Rep 11:9453
Gill AAS, Singh S, Thapliyal N, Karpoormath R (2019) Nanomaterial-based optical and electrochemical techniques for detection of methicillin-resistant Staphylococcus aureus: a review. Microchim Acta. https://doi.org/10.1007/s00604-018-3186-7
Guo Y, Song G, Sun M, Wang J, Wang Y (2020) Prevalence and therapies of antibiotic-resistance in Staphylococcus aureus. Front Cell Infect Microbiol 10:107. https://doi.org/10.3389/fcimb.2020.00107
Hindy JR, Haddad SF, Kanj SS (2022) New drugs for methicillin-resistant Staphylococcus aureus skin and soft tissue infections. Curr Opin Infect Dis 35:112–119. https://doi.org/10.1097/QCO.0000000000000800
Hu C, Zhang F, Long L, Kong Q, Luo R, Wang Y (2020) Dual-responsive injectable hydrogels encapsulating drug-loaded micelles for on-demand antimicrobial activity and accelerated wound healing. J Control Release. https://doi.org/10.1016/j.jconrel.2020.05.010
Ibrahim UH, Devnarain N, Omolo CA, Mocktar C, Govender T (2021) Biomimetic pH/lipase dual responsive vitamin-based solid lipid nanoparticles for on-demand delivery of vancomycin. Int J Pharm. https://doi.org/10.1016/j.ijpharm.2021.120960
Iyer RN (2022) 7.02 - Beta lactam. Kenakin TBT-CP. Elsevier, Oxford, pp 3–63
Jhawat V, Gulia M, Gupta S, Maddiboyina B, Dutt R (2020) Integration of pharmacogenomics and theranostics with nanotechnology as quality by design (QbD) approach for formulation development of novel dosage forms for effective drug therapy. J Control Release. https://doi.org/10.1016/j.jconrel.2020.08.039
Jones RN, Mendes RE, Sader HS (2010) Ceftaroline activity against pathogens associated with complicated skin and skin structure infections: results from an international surveillance study. J Antimicrob Chemother. https://doi.org/10.1093/jac/dkq252
Karthikeyan C, Varaprasad K, Akbari-Fakhrabadi A, Hameed ASH, Sadiku R (2020) Biomolecule chitosan, curcumin and ZnO-based antibacterial nanomaterial, via a one-pot process. Carbohydr Polym. https://doi.org/10.1016/j.carbpol.2020.116825
Kurosu M, Siricilla S, Mitachi K (2013) Advances in MRSA drug discovery: Where are we and where do we need to be? Expert Opin Drug Discov. https://doi.org/10.1517/17460441.2013.807246
Lee AS, de Lencastre H, Garau J, Kluytmans J, Malhotra-Kumar S, Peschel A, Harbarth S (2018) Methicillin-resistant Staphylococcus aureus. Nat Rev Dis Prim 4:18033
Li J, Wei Y, Wang J, Li Y, Shao G, Feng Z, Xiong Q (2022) Characterization of mutations in DNA gyrase and topoisomerase IV in field strains and in vitro selected quinolone-resistant mycoplasma hyorhinis mutants. Antibiotics. https://doi.org/10.3390/antibiotics11040494
Lin J, Zhou D, Steitz TA, Polikanov YS, Gagnon MG (2018) Ribosome-targeting antibiotics: modes of action, mechanisms of resistance, and implications for drug design. Annu Rev Biochem 87:451–478
Lu H, Butler JA, Britten NS, Venkatraman PD, Rahatekar SS (2021) Natural antimicrobial nano composite fibres manufactured from a combination of alginate and oregano essential oil. Nanomaterials. https://doi.org/10.3390/nano11082062
Maddiboyina B, Asthana A, Asthana GS, Singh S, Ramya M, Sunnapu O, Kotla N (2015) Formulation and characterization of polycarbophil coated mucoadhesive microspheres of repaglinide. J Pharm Sci Res 7(11):972–977
Maddiboyina B, Hanumanaik M, Nakkala RK et al (2020) Formulation and evaluation of gastro-retentive floating bilayer tablet for the treatment of hypertension. Heliyon 6:e05459
Maddiboyina B, Shanmugapriya J, Rasala S, Sivaraman G (2021a) Bioinspired Nanomaterials for Drug Delivery. In: Bioinspired Nanomater. Synth. Emerg. Appl., Materials. Materials Research Forum LLC, pp 63–95
Maddiboyina B, Desu PK, Vasam M, Challa VT, Surendra AV, Rao RS, Alagarsamy S, Jhawat V (2021b) An insight of nanogels as novel drug delivery system with potential hybrid nanogel applications. J Biomater Sci Polym Ed. https://doi.org/10.1080/09205063.2021.1982643
Maddiboyina B, Jhawat V, Nakkala RK, Desu PK, Gandhi S (2021c) Design expert assisted formulation, characterization and optimization of microemulsion based solid lipid nanoparticles of repaglinide. Prog Biomater. https://doi.org/10.1007/s40204-021-00174-3
Maddiboyina B, Nakkala RK, Sivaraman G (2022a) Biomass-derived mesoporous carbon nanomaterials for drug delivery and imaging applications. In: Biomass‐derived carbon mater. pp 129–146
Maddiboyina B, Sunaapu OP, Chandrashekharappa S, Sivaraman G (2022b) Advantages and limitations of functionalized nanomaterials based electrochemical sensors environmental monitoring. In: Functionalized nanomaterial-based electrochemical sensors, Princ Fabr Methods, Appl. https://doi.org/10.1016/B978-0-12-823788-5.00016-8
Maddiboyina B, Vanamamalai HK, Roy H, Ramaiah GS, Kavisri M, Moovendhan M (2023) Food and drug industry applications of microalgae spirulina platensis: a review. J Basic Microbiol. https://doi.org/10.1002/jobm.202200704
Maddina BY, Asthana GS, Asthana A (2016) A Review on current scenario of spirulina drug delivery systems. World J Pharm Sci 4:86–89
Mat Rani NNI, Mustafa Hussein Z, Mustapa F, Azhari H, Sekar M, Chen XY, Mohd Amin MCI (2021) Exploring the possible targeting strategies of liposomes against methicillin-resistant Staphylococcus aureus (MRSA). Eur J Pharm Biopharm. https://doi.org/10.1016/j.ejpb.2021.04.021
Maya-Martinez R, Alexander JAN, Otten CF et al (2019) Recognition of peptidoglycan fragments by the transpeptidase PBP4 From Staphylococcus aureus. Front Microbiol 9:3223. https://doi.org/10.3389/fmicb.2018.03223
Michaelidou M, Karageorgos SA, Tsioutis C (2020) Antibiotic use and antibiotic resistance: public awareness survey in the Republic of Cyprus. Antibiotics. https://doi.org/10.3390/antibiotics9110759
Momin M, Mishra V, Gharat S, Omri A (2021) Recent advancements in cellulose-based biomaterials for management of infected wounds. Expert Opin Drug Deliv. https://doi.org/10.1080/17425247.2021.1989407
Mosselhy DA, Assad M, Sironen T, Elbahri M (2021) Nanotheranostics: a possible solution for drug-resistant Staphylococcus aureus and their Biofilms? Nanomater. https://doi.org/10.3390/nano11010082
Murei A, Pillay K, Govender P, Thovhogi N, Gitari WM, Samie A (2021) Synthesis, characterization and in vitro antibacterial evaluation of Pyrenacantha grandiflora conjugated silver nanoparticles. Nanomaterials. https://doi.org/10.3390/nano11061568
Nolan AC, Zeden MS, Kviatkovski I, Campbell C, Urwin L, Corrigan RM, Gründling A, O’Gara JP (2023) Purine nucleosides interfere with c-di-AMP levels and act as adjuvants to re-sensitize MRSA To β-lactam antibiotics. Mbio. https://doi.org/10.1128/mbio.02478-22
Norrrahim MNF, Nurazzi NM, Jenol MA, Farid MAA, Janudin N, Ujang FA, Yasim-Anuar TAT, Syed Najmuddin SUF, Ilyas RA (2021) Emerging development of nanocellulose as an antimicrobial material: an overview. Mater Adv. https://doi.org/10.1039/d1ma00116g
Ogston A (1882) Micrococcus Poisoning. J Anat Physiol 17(Pt 1):24–58
Onyeji CO, Nightingale CH, Marangos MN (1994) Enhanced killing of methicillin-resistant Staphylococcus aureus in human macrophages by liposome-entrapped vancomycin and teicoplanin. Infection. https://doi.org/10.1007/BF01715542
Ovung A, Bhattacharyya J (2021) Sulfonamide drugs: structure, antibacterial property, toxicity, and biophysical interactions. Biophys Rev 13:259–272
Placha D, Jampilek J (2021) Chronic inflammatory diseases, anti-inflammatory agents and their delivery nanosystems. Pharmaceutics. https://doi.org/10.3390/pharmaceutics13010064
Raineri EJM, Altulea D, van Dijl JM (2022) Staphylococcal trafficking and infection-from “nose to gut” and back. FEMS Microbiol Rev. https://doi.org/10.1093/femsre/fuab041
Report NDS (2020) Centers for Disease Control and Prevention. National Diabetes Statistics Report, 2020. Atlanta, GA: Centers for Disease Control and Prevention, U.S. Dept of Health and Human Services; 2020. Natl. Diabetes Stat. Rep.
Reygaert WC (2018) An overview of the antimicrobial resistance mechanisms of bacteria. AIMS Microbiol 4:482–501
Roger C, Roberts JA, Muller L (2018) Clinical pharmacokinetics and pharmacodynamics of oxazolidinones. Clin Pharmacokinet 57:559–575
Roy H, Nayak BS, Maddiboyina B, Nandi S (2022) Chitosan based urapidil microparticle development in approach to improve mechanical strength by cold hyperosmotic dextrose solution technique. J Drug Deliv Sci Technol 76:103745
Sakr A, Brégeon F, Mège JL, Rolain JM, Blin O (2018) Staphylococcus aureus nasal colonization: an update on mechanisms, epidemiology, risk factors, and subsequent infections. Front Microbiol 9:2419. https://doi.org/10.3389/fmicb.2018.02419
Samia NI, Robicsek A, Heesterbeek H, Peterson LR (2022) Methicillin-resistant staphylococcus aureus nosocomial infection has a distinct epidemiological position and acts as a marker for overall hospital-acquired infection trends. Sci Rep 12:17007
Sanga B, Kharel MKBT-RM in BS (2022) Chloramphenicol. https://doi.org/10.1016/B978-0-12-824315-2.00349-3
Singh S, Numan A, Somaily HH, Gorain B, Ranjan S, Rilla K, Siddique HR, Kesharwani P (2021) Nano-enabled strategies to combat methicillin-resistant Staphylococcus aureus. Mater Sci Eng C 129:112384
Tamahkar E (2021) Bacterial cellulose/poly vinyl alcohol based wound dressings with sustained antibiotic delivery. Chem Pap. https://doi.org/10.1007/s11696-021-01631-w
Tong SYC, Davis JS, Eichenberger E, Holland TL, Fowler VG (2015) Staphylococcus aureus infections: epidemiology, pathophysiology, clinical manifestations, and management. Clin Microbiol Rev. https://doi.org/10.1128/CMR.00134-14
Turner NA, Sharma-Kuinkel BK, Maskarinec SA, Eichenberger EM, Shah PP, Carugati M, Holland TL, Fowler VG (2019) Methicillin-resistant Staphylococcus aureus: an overview of basic and clinical research. Nat Rev Microbiol 17:203–218
Vanamala K, Bhise K, Sanchez H, Kebriaei R, Luong D, Sau S, Abdelhady H, Rybak MJ, Andes D, Iyer AK (2021) Folate functionalized lipid nanoparticles for targeted therapy of methicillin-resistant staphylococcus aureus. Pharmaceutics. https://doi.org/10.3390/pharmaceutics13111791
Vijayakumar S, Malaikozhundan B, Parthasarathy A, Saravanakumar K, Wang MH, Vaseeharan B (2020) Nano biomedical potential of biopolymer chitosan-capped silver nanoparticles with special reference to antibacterial, antibiofilm, anticoagulant and wound dressing material. J Clust Sci. https://doi.org/10.1007/s10876-019-01649-x
Wan TW, Teng LJ, Yamamoto T (2021) Unique surface structures of community-associated methicillin-resistant Staphylococcus aureus ST8/SCCmecIVl. J Microbiol Immunol Infect. https://doi.org/10.1016/j.jmii.2020.09.008
Wang P, Jiang S, Li Y, Luo Q, Lin J, Hu L, Liu X, Xue F (2021) Virus-like mesoporous silica-coated plasmonic Ag nanocube with strong bacteria adhesion for diabetic wound ulcer healing. Nanomed Nanotechnol Biol Med. https://doi.org/10.1016/j.nano.2021.102381
Williams VR, Callery S, Vearncombe M, Simor AE (2009) The role of colonization pressure in nosocomial transmission of methicillin-resistant Staphylococcus aureus. Am J Infect Control. https://doi.org/10.1016/j.ajic.2008.05.007
Wong YT, Yeung CS, Chak WL, Cheung CY (2023) Methicillin-resistant Staphylococcus aureus nasal carriage among patients on haemodialysis with newly inserted central venous catheters. Int Urol Nephrol. https://doi.org/10.1007/s11255-023-03521-4
Wunderink RG, Niederman MS, Kollef MH, Shorr AF, Kunkel MJ, Baruch A, McGee WT, Reisman A, Chastre J (2012) Linezolid in methicillin-resistant staphylococcus aureus nosocomial pneumonia: a randomized, controlled study. Clin Infect Dis. https://doi.org/10.1093/cid/cir895
Yuan Q, Zhao Y, Zhang Z, Tang Y (2021) On-demand antimicrobial agent release from functionalized conjugated oligomer-hyaluronic acid nanoparticles for tackling antimicrobial resistance. ACS Appl Mater Interfaces. https://doi.org/10.1021/acsami.0c19283
Zhang C, Zhao W, Bian C, Hou X, Deng B, McComb DW, Chen X, Dong Y (2019) Antibiotic-derived lipid nanoparticles to treat intracellular Staphylococcus aureus. ACS Appl Bio Mater. https://doi.org/10.1021/acsabm.8b00821
Zhong X, Tong C, Liu T, Li L, Liu X, Yang Y, Liu R, Liu B (2020) Silver nanoparticles coated by green graphene quantum dots for accelerating the healing of: MRSA-infected wounds. Biomater Sci. https://doi.org/10.1039/d0bm01398f
Zimmermann P, Ziesenitz VC, Curtis N, Ritz N (2018) The Immunomodulatory effects of macrolides—a systematic review of the underlying mechanisms. Front Immunol 9:302. https://doi.org/10.3389/fimmu.2018.00302